|
|
 |
 | Medical News Releases > University Groups > School of Medicine >
Rheumatology
| News Stories & Tip Sheets: |
Showing Stories 1 through 9 of 9.
- Show Home
|
|
Immune system's soldiers get better with experience
Major immune system branch has hidden ability to learn
Jan. 26,
2009 -- Half of the immune system has a hidden talent, researchers at the School of Medicine have discovered. They found the innate immune system, long recognized as a specialist in rapidly and aggressively combating invaders, has cells that can learn from experience and fight better when called into battle a second time. Scientists previously thought any such ability was limited to the immune system's other major branch, the adaptive immune system.
|
Aspirin, the mighty drug
Versatility and low cost keep aspirin popular among consumers
July 23,
2007 -- With today's rapid rate of medical advancement, it's hard to imagine that an over-the-counter drug introduced in the 1800s could still be widely popular and effective. But due to its low cost and versatility, millions of Americans still keep a bottle of aspirin in their medicine cabinets.
|
Prestigious honor
Three faculty members elected to National Academy of Sciences
May 3,
2007 -- Three Washington University scientists are among the 72 members and 18 foreign associates elected to the National Academy of Sciences. Election to the academy is considered one of the highest honors that can be accorded a U.S. scientist or engineer.
|
Killer cells
"License to kill" enables powerful immune attack cells in mice
Aug. 3,
2005 -- Scientists have discovered that a group of important immune system cells has a surprising resemblance to cinematic British superspy James Bond: the cells receive a "license" that allows them to unleash their most potent attacks on enemies.
|
Self-efficacy and arthritis
Pilot study finds poorer outcomes for African-Americans with rheumatoid arthritis
July 11,
2005 --
 |
| Arthritis can hit harder in African-Americans. |
A pilot study comparing the results of treatment for rheumatoid arthritis in African-Americans and Caucasians has revealed that African-Americans are more likely to suffer pain and disability from the disorder. Researchers at Washington University School of Medicine in St. Louis studied a group of 33 African-Americans and 67 Caucasians and found that both disease activity and the resulting disabilities were worse in African-Americans. Further analysis showed this was linked primarily to socio-economic status rather than race.
|
Targeting inflammation
Enzyme?s newly discovered role may make it target for arthritis treatment
June 23,
2005 -- Scientists have found a new role for a previously identified enzyme that may make it a target for anti-inflammatory treatments.
|
Giving back to medicine
$5.5 million gift benefits five WUSM specialty areas
Feb. 21,
2005 -- The School of Medicine will benefit from a $5.5 million gift from the estate of Hilda Niess. The money will specifically benefit five medical specialty areas: Department of Radiology/Mallinckrodt Institute of Radiology; Center for the Study of Nervous System Injury; Siteman Cancer Center; Alzheimer's Disease Research Center; and the Division of Rheumatology.
|
'A role model, clinician and educator'
New director of pediatric rheumatology & immunology looks toward new medicines
Oct. 14,
2004 --
 |
| Photo by Bob Boston |
| White examines a patient. |
Juvenile rheumatoid arthritis expert Andrew J. White, M.D., has been named the division director of pediatric rheumatology and immunology. White is known for his role in the study of new drugs for the treatment of juvenile rheumatoid arthritis and other autoimmune diseases.
|
Keeping a 'leash' on lupus
'Leash' protein may help keep B cells from attacking body tissue
Sept. 22,
2004 --
 |
| B cells |
Scientists at the School of Medicine have identified a protein that can reduce the chances immune B cells will erroneously attack the body's own tissues, causing autoimmune disorders like lupus, allergies, arthritis and diabetes. The protein is the first of its kind to be identified in B cells and could provide scientists with a new target for treating such conditions.
|
Showing Stories 1 through 9 of 9.
- Show Home
|
|
Affiliated with Barnes-Jewish Hospital and St. Louis Children's Hospital, members of BJC HealthCare.
Please contact us and let us know how we can assist you.
Technical problems with this Web site? Email questions or comments.
Please review the WUSTL News & Information copyright/privacy policy.
| |
|
| | |
|
Print ready page